Loading data
EVEXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 194.7 m USD | 129.84 m USD | 105.58 m USD | 51.86 m USD | 13.28 m USD |
| Selling, general and administrative expense | 30.69 m USD | 26.53 m USD | 23.1 m USD | 32.86 m USD | 4.9 m USD |
| Operating profit | -225.39 m USD | -156.37 m USD | -130.55 m USD | -189.49 m USD | -18.18 m USD |
| Interest expense | 10.14 m USD | 3.66 m USD | 252 k USD | 0 USD | 0 USD |
| Profit before tax | -223.25 m USD | -137.66 m USD | -126.09 m USD | -173.1 m USD | -18.26 m USD |
| Income tax expense | 1.01 m USD | 507 k USD | 1.57 m USD | 933 k USD | 0 USD |
| Net income (reported basis) | -224.26 m USD | -138.17 m USD | -127.66 m USD | -174.03 m USD | -18.26 m USD |
| Basic earnings per share | -0.7 USD/share | -0.48 USD/share | -0.46 USD/share | -0.68 USD/share | -0.08 USD/share |
| Diluted earnings per share | -0.7 USD/share | -0.48 USD/share | -0.46 USD/share | -0.68 USD/share | -0.08 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.